P96 Repeat Administration of GL67A/pGM169 Is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202678.338

Related search